Curiosity Before Conviction: Healthcare Founder Takeaways from Laura Hilty’s TEDx Talk
HealthX Principal Laura Hilty recently took the TEDx stage to explore a question that every founder, investor, and builder should care deeply about: Why do great ideas fail?
It’s a question Laura has spent much of her career thinking about—first as an operator launching software products and leading strategy in clinical research technology, and now as an investor working with early-stage healthcare founders at HealthX.
In her TEDx Talk, Laura makes the case that great ideas rarely fail because people are not smart enough, ambitious enough, or visionary enough. More often, they fail because teams lose sight of the problem they set out to solve.
They fall in love with the product. They optimize for what is right in front of them. Then, they mistake internal conviction for customer understanding.
And in complex industries like healthcare, where buyers, users, incentives, workflows, and outcomes are often misaligned, that can be the difference between building something interesting and building something that truly matters.
We hope you’ll watch Laura’s full talk. For founders building in healthcare, we pulled out a few takeaways that felt especially relevant.
1. Don’t fall in love with the product. Stay attached to the problem.
One of Laura’s clearest messages is also one of the hardest disciplines for founders to maintain: stay relentlessly committed to the problem, not the solution.
She points to Kodak and Apple as two very different examples of companies that saw the future but still struggled. Kodak invented the digital camera but remained tied to the business model it already knew. Apple’s Lisa was technologically impressive, but it was too expensive, too early, and not yet supported by the broader ecosystem customers needed.
The lesson for founders is not simply that timing matters. It is that vision alone is not enough.
Your first job is not to prove that your product is right. Your first job is to keep learning whether you are solving the right problem, for the right person, in the right way, at the right time.
That distinction matters even more in healthcare, where the cost of misunderstanding the problem is not just wasted capital or slower growth. It can mean failing to improve care, reduce burden, expand access, or help patients when it matters most.
2. In healthcare, the “customer” is rarely one person.
Healthcare is full of complicated stakeholder dynamics.
A health system may buy the technology. A clinician may use it. A patient may experience the outcome. A caregiver may support the workflow. A payer may benefit from the savings. An administrator may control implementation. A nurse may determine whether the tool actually gets adopted.
That means founders need to understand more than the buyer. They need to understand the entire ecosystem surrounding the problem.
Who feels the pain most acutely?
Who has budget?
Who has influence?
Who has to change their workflow?
Who benefits if the product works?
Who loses time, control, revenue, or status if it does?
When the buyer and the user are not the same person, and when the user is critical to the buyer’s goals, the problem becomes more nuanced. Founders who miss that complexity often end up with a product that sounds compelling in a pitch but struggles in implementation.
The best healthcare founders map the whole system before they build around one stakeholder’s perspective.
3. “No market need” often means “not enough problem understanding.”
Laura references a familiar startup failure pattern: companies often fail because there is no market need.
But her interpretation goes a layer deeper. “No market need” is often not a failure of creativity. It is a failure to fully understand the problem.
In healthcare, a problem may be real, painful, and widespread, but still not translate into a viable business unless the founder understands the workflow, incentives, urgency, budget cycle, regulatory environment, implementation burden, and willingness to pay.
Enthusiasm is not the same as validation.
A pilot is not the same as adoption.
A painful problem is not always a funded priority.
For founders, the deeper question is not simply, “Do people like this idea?” It is: Is this problem painful enough, urgent enough, and owned by someone with enough motivation and authority to act?
That level of clarity only comes from staying close to customers, asking better questions, and resisting the temptation to rush too quickly into selling.
4. Curiosity should become infrastructure.
Curiosity is easy to celebrate as a personal trait. Laura pushes it further. She argues that curiosity has to be embedded into how organizations make decisions. That is an important lesson for founders.
In the earliest days, curiosity often lives naturally inside the founding team. Founders are close to customers. They hear every objection. They watch every workflow break. They feel every implementation challenge personally.
But as companies scale, distance grows. Teams form around functions. Metrics become narrower. Sales, product, customer success, clinical, finance, and operations may each see only part of the picture. That is when companies need systems that keep learning alive.
For healthcare startups, that might look like regular customer shadowing, implementation retrospectives, win/loss reviews, churn interviews, product councils, clinical advisory sessions, or cross-functional reviews that force the team to compare what each function is seeing.
Curiosity should not depend on one founder asking good questions—it should become part of the company’s operating system.
5. Ego quietly distorts decision-making.
One of the most honest parts of Laura’s talk is her discussion of ego.
Founders need conviction. They need ambition. They need the resilience to keep going when building is hard, customers are slow, and the market is skeptical.
But ego becomes dangerous when identity gets too tightly attached to a specific solution, strategy, or story.
Once a founder has raised money on a vision, hired a team around it, sold customers on it, and repeated it hundreds of times, it becomes painful to question whether that direction is still right.
Ego can distort which feedback gets trusted, which signals get ignored, and when a company is willing to pivot.
The best founders are not ego-free. They are often deeply ambitious. But they redirect that ambition toward the mission, the learning, and the future growth of the company—not toward being right about the first answer.
6. In healthcare, the goal is not to “fail fast.” It is to learn responsibly.
“Fail fast” is a common Silicon Valley mantra, but Laura makes an important distinction: in healthcare and clinical research, failing fast is not always an acceptable framework when people’s lives are at stake.
That does not mean healthcare founders should move slowly or avoid experimentation. It means the learning has to be thoughtful, ethical, and grounded in the realities of the industry.
Founders still need to test assumptions, validate demand, and be willing to change direction. But in healthcare, the better framing may be: Learn responsibly.
Stay unattached to the solution. Stay committed to the problem. Move with urgency, but do the work to understand the clinical, operational, financial, and human implications of what you are building.
7. Certainty is earned from curiosity.
Laura closes with a line that captures the heart of the talk: Your certainty will be earned from your curiosity. That is a powerful reminder for founders.
The most compelling companies are not built on bravado. They are built by teams that ask better questions, listen carefully, challenge their assumptions, and remain humble enough to keep learning even as they gain traction.
In healthcare, that kind of curiosity is not a soft skill. It is a strategic advantage. It helps founders understand the full problem, design around real workflows, navigate stakeholder complexity, and build companies that can create lasting impact.
At HealthX, we believe entrepreneurs are the key to unlocking the potential of health and prosperity for all. Laura’s talk is a timely reminder that the founders most likely to change healthcare are not just the ones with bold ideas. They are the ones with the discipline to stay curious long enough to solve the right problem.
